Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Celularity (CELU) Return on Sales (2020 - 2025)

Celularity has reported Return on Sales over the past 6 years, most recently at 4.37% for Q3 2025.

  • Quarterly results put Return on Sales at 4.37% for Q3 2025, down 264.0% from a year ago — trailing twelve months through Sep 2025 was 3.49% (down 276.0% YoY), and the annual figure for FY2024 was 1.07%, up 755.0%.
  • Return on Sales for Q3 2025 was 4.37% at Celularity, down from 4.28% in the prior quarter.
  • Over the last five years, Return on Sales for CELU hit a ceiling of 12.67% in Q2 2022 and a floor of 30.64% in Q1 2021.
  • Median Return on Sales over the past 5 years was 1.73% (2024), compared with a mean of 6.73%.
  • Biggest five-year swings in Return on Sales: skyrocketed 3285bps in 2022 and later crashed -2899bps in 2023.
  • Celularity's Return on Sales stood at 0.83% in 2021, then skyrocketed by 812bps to 5.92% in 2022, then tumbled by -87bps to 0.79% in 2023, then tumbled by -2551bps to 19.32% in 2024, then skyrocketed by 77bps to 4.37% in 2025.
  • The last three reported values for Return on Sales were 4.37% (Q3 2025), 4.28% (Q2 2025), and 1.73% (Q1 2025) per Business Quant data.